Sirolimus for Leigh Syndrome
NCT06843811
·
clinicaltrials.gov ↗
PHASE2
Phase
ENROLLING_BY_INVITATION
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Leigh Syndrome
Interventions
DRUG:
Sirolimus
Sponsor
Matthew Demczko